Investigation of Parvovirus B19 IgM and IgG Positivity Rates in Pediatric Hematology Patients

Abstract

Human parvovirus B19 is a frequent etiologic agent causing erythema infectiosum in children. It has recently been suggested that parvovirus B19 may be latent after infection and cause reactive infections especially in immunosuppressed patients with hematological problems. In this study, we aimed to investigate the parvovirus B19 immunoglobulin M (IgM) and immunoglobulin G (IgG) seropositivity rates of patients evaluated in a pediatric hematology clinic. We retrospectively screened the laboratory results of parvovirus B19 IgM and IgG antibody assays of children less than 18 years, who consulted pediatric in-and-outpatient clinics between 2013 and 2016. Parvovirus B19 IgM and IgG antibodies were investigated in serum samples by using enzyme-linked immunosorbent assay method in the Medical Microbiology Laboratory. Parvovirus B19 IgM antibodies were detected in 109 of 602 patients attending pediatric hematology clinics (18.1%). Parvovirus B19 IgG antibody was detected in 244 of 952 patients attending pediatric hematology clinics (25.6%). Parvovirus B19 IgM and IgG positivity in samples from pediatric in-and-outpatient clinics other than pediatric hematology were 2.8% and 35.7%, respectively. Parvovirus IgM and IgG positivity in serum samples sent from the pediatric hematology clinic and outpatients was statistically significant compared with those sent from pediatric clinics other than pediatric hematology (p = 0.0001 and p = 0.0008, respectively). The higher detection rate of serum parvovirus B19 IgM positivity in patients under the follow-up of pediatric hematology clinics suggests that immune suppression-related viral reinfection or persistence may occur in these patients.

Keywords

parvovirus B19 - IgM - IgG - pediatric patient

• References

• 1 Parvoviruses. In: Murray PR, Rosenthal KS, Pfaller MA. , eds. Medical Microbiology. 5th ed. Philadelphia: Elsevier; 2005: 573-577
• 2 Anderson MJ, Higgins PG, Davis LR. , et al. Experimental parvoviral infection in humans. J Infect Dis 1985; 152 (02) 257-265
• 3 Abkowitz JL, Brown KE, Wood RW, Kovach NL, Green SW, Young NS. Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis 1997; 176 (01) 269-273
• 4 Brown T, Anand A, Ritchie LD, Clewley JP, Reid TM. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984; 2 (8410): 1033-1034
• 5 Chernak E, Dubin G, Henry D. , et al. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. Clin Infect Dis 1995; 20 (01) 170-173
• 6 Eis-Hübinger AM, Dieck D, Schild R, Hansmann M, Schneweis KE. Parvovirus B19 infection in pregnancy. Intervirology 1998; 41 (4–5): 178-184
• 7 Nagai K, Morohoshi T, Kudoh T, Yoto Y, Suzuki N, Matsunaga Y. Transient erythroblastopenia of childhood with megakaryocytopenia associated with human parvovirus B19 infection. Br J Haematol 1992; 80 (01) 131-132
• 8 Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987; 317 (05) 287-294
• 9 Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002; 15 (03) 485-505
• 10 Cherry JD. Human parvovirus B19. In: Feigin RD, Cherry JD, Demler GJ, Kaplan SL. , eds. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelpia: Saunders; 2004: 1796-809
• 11 Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988; 25 (02) 151-153
• 12 Çolak D, Öğünç D, Aktekin M, Başustaoğlu AH, Gültekin M. Seroprevalance of Parvovirus at the children aged between 4–6 years old in Antalya region [Article in Turkish]. Klimik Derg 1998; 11: 61-62
• 13 Bahar A, Kocabeyoğlu Ö, Karademir F, Emekdaş G, Göçmen İ, Mete Z. Prevalance of Parvovirus B 19 infection in children. Turk J Infect 2001; 15: 283-285
• 14 Türk Dağı H, Ozdemir M, Baykan M, Baysal B. Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey [Article in Turkish]. Mikrobiyol Bul 2010; 44 (03) 467-472
• 15 Gupta V, Saini I, Nath G. Prevalence of parvovirus B 19 infection in children with aplastic anemia. Indian Pediatr 2013; 50 (05) 489-491
• 16 Zaki MS, Hassan SA, Seleim T, Lateef RA. Parvovirus B19 infection in children with a variety of hematological disorders. Hematology 2006; 11 (04) 261-266
• 17 Işik N, Ağaçfidan A, Ağirbaşli H. , et al. The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients [Article in Turkish]. Mikrobiyol Bul 2003; 37 (04) 277-283
• 18 Us T, Ozune L, Kasifoglu N, Akgun Y. The investigation of parvovirus B19 infection in patients with haematological disorders by using PCR and ELISA techniques. Braz J Infect Dis 2007; 11 (03) 327-330